Therefore, approximately 2 months after Lm-based vaccination, mice were challenged with tumor, and received ICI (either anti-PD-1, anti-CTLA-4, or anti-PD-L1) every 10 days subsequently, in order to maintain anti-tumor T cell function. Here, CTLA4 is linked to neoplasm.